Development of a new biomarker for Parkinson disease by measuring alpha-synuclein fibril in CSF

Keita Kakuda

Presentation information

Oral Session

[O-33] Parkinsonism and Related disorders (Biomarkers)

Fri. May 25, 2018 9:45 AM - 11:15 AM Room 9 (Royton Sapporo / Regent Hall （2F）)

Chair: Hideki Mochizuki(Department of Neurology, Osaka University Graduate School of Medicine)Commentator: Ronald Melki(Centre National de la Recherche Scientifique (CNRS), France)

[O-33-6] Development of a new biomarker for Parkinson disease by measuring alpha-synuclein fibril in CSF

^○Keita Kakuda¹, Kensuke Ikenaka¹, Katsuya Araki², Yuta Kajiyama¹, Kuni Konaka¹, Takuma Omichi³, Takahiko Tokuda³, Masatomo So⁴, Yuji Goto⁴, Hideki Mochizuki¹ (1.Department of Neurology, Osaka University, 2.Department of Neurology, Toyonaka Municipal Hospital, 3.Department of Neurology, Kyoto Prefectural University of Medicine, 4.Institute for Protein Research, Osaka University)

Abstract password authentication.
Password is written on a pocket program and name badge.